Ditchcarbon
  • Customers
  1. Organizations
  2. Dr Reddys Laboratories
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 6 days ago

Dr Reddys Laboratories

Company website

Dr. Reddy's Laboratories, a prominent player in the global pharmaceutical industry, is headquartered in Hyderabad, India. Founded in 1984, the company has established itself as a leader in the development and manufacturing of a wide range of generic medications, active pharmaceutical ingredients (APIs), and proprietary products. With a strong presence in markets across North America, Europe, and Asia, Dr. Reddy's is committed to providing affordable healthcare solutions. The company’s core offerings include generic formulations, biosimilars, and over-the-counter products, distinguished by their quality and innovation. Dr. Reddy's has achieved significant milestones, including numerous product launches and strategic partnerships, solidifying its market position. Recognised for its commitment to sustainability and patient-centric approach, Dr. Reddy's Laboratories continues to make strides in enhancing global health outcomes.

DitchCarbon Score

How does Dr Reddys Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

83

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Dr Reddys Laboratories's score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

91%

Let us know if this data was useful to you

Dr Reddys Laboratories's reported carbon emissions

In 2024, Dr Reddy's Laboratories reported total greenhouse gas emissions of approximately 189,530,000 kg CO2e for Scope 1, 114,655,000 kg CO2e for Scope 2, and 866,992,000 kg CO2e for Scope 3. This represents a significant commitment to reducing their carbon footprint, with a target to achieve a 50.2% reduction in Scope 1 and 2 emissions per million USD revenue by FY2031, based on a FY2021 baseline. This equates to an absolute reduction of about 25%. Additionally, the company aims to reduce absolute Scope 3 emissions by 12.3% within the same timeframe. Dr Reddy's Laboratories has also committed to sourcing 100% renewable power by 2030, further enhancing their sustainability initiatives. The emissions data and reduction targets are aligned with the Science Based Targets initiative (SBTi), ensuring that their goals are consistent with the global effort to limit temperature rise to well below 2°C. The company has demonstrated a proactive approach to climate commitments, with a clear focus on both operational and supply chain emissions, reflecting a comprehensive strategy to address climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
177,841,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
254,563,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dr Reddys Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Dr Reddys Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Dr Reddys Laboratories is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Emcure

IN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Ipca Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Piramal Pharma Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Sun Pharmaceutical Industries

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy